COVID-19 trials registries data warehouse

 Return to trial list

Trial - CTRI/2022/05/042411


Column Value
Trial registration number CTRI/2022/05/042411
Full text link
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

First author
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Dr Sujatha Prabhu P

Contact
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

ramesh.babu@manipal.edu

Registration date
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

2022-05-09

Recruitment status
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Not recruiting

Study design
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

RCT

Allocation
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Randomized

Design
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Parallel

Masking
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Not reported

Center
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

single-center

Study aim
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Long covid

Inclusion criteria
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Participants who will not be practicing Yoga or meditation in their routine day to day life will be included. <br/ > <br/ >Participants with post COVOD-19 symptoms (One month after discharge from hospital or isolation) having American Association of Anesthesiologist (ASA) score I/II will be included in the control /intervention groups. <br/ > <br/ >Participants who will be taking any type of medication including for sleep/anxiety are permitted to be included in the study. <br/ >

Exclusion criteria
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Participants with ASA score III or more will be excluded from the study. <br/ > <br/ >Individuals who practice pranayama or meditation regularly (more the 3 days in a week). <br/ > <br/ >Individuals below 18 years and above 65 years of age will be excluded from the study. <br/ >

Number of arms
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

2

Funding
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Manipal Academy of Higher Education

Inclusion age min
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

18

Inclusion age max
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

65

Countries
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

India

Type of patients
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Patients recovered from covid

Severity scale
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

N/A

Total sample size
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

500

primary outcome
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Identify the current prevalence of long-term debilitating effects in post COVID-19 symptomatic Indian <br/ >adult patients which are lacking. Assist in the clinical management of post-COVID-19 symptomatic <br/ >Indian patients by rehabilitation techniques or preventive measures using Yoga (mainly pranayama) and <br/ >particularly RM to mitigate their debilitating effect or symptoms particularly related to cerebral <br/ >cardiovascular and respiratory problems and improve quality of life.Timepoint: one month

Notes
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

| Declared number of arm (4.0) differs from found arms (5.0)

Phase
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Not reported

Arms
Last imported at : June 2, 2022, 8 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

[{"arm_notes": "", "treatment_id": 2518, "treatment_name": "Meditation+yoga", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]